Association between drug use and diagnosis-related group overspending in cancer patients
AIM To explore the association between drug use and diagnosis-related group(DRG)overspending in cancer patients,and to provide basis for controlling costs of drug use and rational drug use.METHODS Patients included in the RE1A disease group from January to December 2022 in a tertiary medical institution were used as the study data,and univariate Logistic regression and multivariate Logistic regression were used to assess the effect of different types of drugs on DRG overspending.RESULTS A total of 1 729 patients were included in the study and 431 patients presented with DRG overspending.The results of multivariable Logistic regression analyses revealed a significant association between the use of proprietary Chinese medicines(OR=1.09,95％CI:1.04-1.14,P＜0.001),antineoplastic drugs(OR=1.07,95％CI:1.06-1.08,P＜0.001),haematocyte stimulating factors(OR=1.08,95％CI:1.05-1.10,P＜0.001),and other medications(OR=1.18,95％CI:1.13-1.22,P＜0.001)with DRG overspending.However,there was no correlation between hepatoprotective drugs,acid-suppressing drugs,analgesic drugs,and antiemetic drugs with DRG overspending(P＞0.05).CONCLUSION The use of proprietary Chinese medicines,antineoplastic drugs,blood cell stimulating factors,and other kinds of drugs are associated with DRG overspending in oncology patients,and clinical control should be strengthened to reduce the cost of drugs,so as to better adapt to the DRG payment method.
cancer patientmedicinediagnosis-related group overspendingassociation
国家科技期刊平台
NSTL
万方数据
